Liver Metastases of Neuroendocrine Tumors and CCC

作者: Thomas Ettrich , Thomas Seufferlein

DOI: 10.1007/978-3-642-36572-0_6

关键词:

摘要: With an increasing annual incidence of about 5/100,000, neuroendocrine tumors (NET) are relatively rare [1]. They originate from different types hormone-producing cells located not only in endocrine glands like the thyroid but almost every tissue. Even when NET can arise part body, lung (about 30 % all NETs) and gastroenteropancreatic system – so-called GEP (small intestine 17 %, colorectal 12 pancreatic 7 %) most common locations Especially, GEP-NETs often diagnosed at already advanced tumor stage (UICC IV) exhibiting liver metastases. There two groups hormonally inactive (70 active (30 that produce hormones including insulin (insulinoma), gastrin (gastrinoma), or serotonin. The patient’s clinical symptoms depend on type hormone produced: e.g., insulin, hypoglycemia; gastrin, peptic ulcers; serotonin, flush.

参考文章(46)
Sanjay Gupta, Marcella M. Johnson, Ravi Murthy, Kamran Ahrar, Michael J. Wallace, David C. Madoff, Stephen E. McRae, Marshall E. Hicks, Sujaya Rao, Jean-Nicolas Vauthey, Jaffer A. Ajani, James C. Yao, Hepatic Arterial Embolization and Chemoembolization for the Treatment of Patients with Metastatic Neuroendocrine Tumors Variables Affecting Response Rates and Survival Cancer. ,vol. 104, pp. 1590- 1602 ,(2005) , 10.1002/CNCR.21389
Jin Hyoung Kim, Hyun-Ki Yoon, Kyu-Bo Sung, Gi-Young Ko, Dong Il Gwon, Ji Hoon Shin, Ho-Young Song, Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma Cancer. ,vol. 113, pp. 1614- 1622 ,(2008) , 10.1002/CNCR.23787
Jaume Capdevila, Isabel Sevilla, Vicente Alonso, Luís Antón Aparicio, Paula Jiménez Fonseca, Enrique Grande, Juan José Reina, José Luís Manzano, Juan Domingo Alonso Lájara, Jorge Barriuso, Daniel Castellano, Javier Medina, Carlos López, Ángel Segura, Sergio Carrera, Guillermo Crespo, José Fuster, Javier Munarriz, Pilar García Alfonso, Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis BMC Cancer. ,vol. 15, pp. 495- 495 ,(2015) , 10.1186/S12885-015-1512-6
Krista L. Noonan, Hagen F. Kennecke, Howard J. Lim, Renata D’Alpino Peixoto, Peter Pavlovich, Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs Journal of gastrointestinal oncology. ,vol. 5, pp. 247- 252 ,(2014) , 10.3978/J.ISSN.2078-6891.2014.019
John G. Touzios, James M. Kiely, Susan C. Pitt, William S. Rilling, Edward J. Quebbeman, Stuart D. Wilson, Henry A. Pitt, Neuroendocrine hepatic metastases: does aggressive management improve survival? Annals of Surgery. ,vol. 241, pp. 776- 785 ,(2005) , 10.1097/01.SLA.0000161981.58631.AB
Ralf-T. Hoffmann, Philipp M. Paprottka, Agnes Schön, Fabian Bamberg, Alexander Haug, Eva-Maria Dürr, Barbara Rauch, Christoph T. Trumm, Tobias F. Jakobs, Thomas K. Helmberger, Maximilian F. Reiser, Frank T. Kolligs, Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. CardioVascular and Interventional Radiology. ,vol. 35, pp. 105- 116 ,(2012) , 10.1007/S00270-011-0142-X
Niraj J. Gusani, Fady K. Balaa, Jennifer L. Steel, David A. Geller, J. Wallis Marsh, Albert B. Zajko, Brian I. Carr, T. Clark Gamblin, Treatment of Unresectable Cholangiocarcinoma with Gemcitabine-Based Transcatheter Arterial Chemoembolization (TACE): A Single-Institution Experience Journal of Gastrointestinal Surgery. ,vol. 12, pp. 129- 137 ,(2008) , 10.1007/S11605-007-0312-Y
Guido Poggi, A. Amatu, B. Montagna, P. Quaretti, C. Minoia, C. Sottani, L. Villani, B. Tagliaferri, F. Sottotetti, O. Rossi, E. Pozzi, F. Zappoli, A. Riccardi, G. Bernardo, OEM-TACE: A New Therapeutic Approach in Unresectable Intrahepatic Cholangiocarcinoma CardioVascular and Interventional Radiology. ,vol. 32, pp. 1187- 1192 ,(2009) , 10.1007/S00270-009-9694-4
E Mitry, E Baudin, M Ducreux, J-C Sabourin, P Rufié, T Aparicio, P Lasser, D Elias, P Duvillard, M Schlumberger, P Rougier, Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin British Journal of Cancer. ,vol. 81, pp. 1351- 1355 ,(1999) , 10.1038/SJ.BJC.6690325
Alexander S. Ho, Joel Picus, Michael D. Darcy, Benjamin Tan, Jennifer E. Gould, Thomas K. Pilgram, Daniel B. Brown, Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. American Journal of Roentgenology. ,vol. 188, pp. 1201- 1207 ,(2007) , 10.2214/AJR.06.0933